BNDES Participações S.A. - BNDESPAR
+29.46%
3M Return
$13.030
+0.318 (+2.44%)At close
JBS N.V. is Netherlands-based Company primarily engaged in the food and protein processing industry. The Company focuses on the production and global distribution of animal protein and food products to retail, foodservice, and industrial clients. The Company has in its offer poultry, pork, beef, lamb, fish and plant-based products. In addition, the Company operates in sectors such as leather, biodiesel, fertilizers, collagen, sausage casings, hygiene and beauty, metal packaging, transportation, waste management solutions. The Company is active worldwide in 17 countries and is listed on The New York Stock Exchange (NYSE).
JBS appears to be a good buy right now due to its current price of $13.03, which is significantly below the analyst price targets of $17.50 and $18. This suggests a potential upside of over 30%. Additionally, the forward P/E ratio of 3.87 indicates that the stock is undervalued compared to its earnings potential. However, the main risk is the recent net loss of $102 million in Q2 2026, which reflects challenges in profitability that investors should monitor closely.

Moderna and Merck's Personalized Cancer Vaccine Trial Shows Positive Results

JBS Proposes Acquisition of Pilgrim's Pride Shares

JBS Reports Q2 2026 Earnings Highlights

JBS Proposes Acquisition of Pilgrim's Pride

JBS Reports Q2 2026 Financial Results with Mixed Performance
JBS N.V. is Netherlands-based Company primarily engaged in the food and protein processing industry. The Company focuses on the production and global distribution of animal protein and food products to retail, foodservice, and industrial clients. The Company has in its offer poultry, pork, beef, lamb, fish and plant-based products. In addition, the Company operates in sectors such as leather, biodiesel, fertilizers, collagen, sausage casings, hygiene and beauty, metal packaging, transportation, waste management solutions. The Company is active worldwide in 17 countries and is listed on The New York Stock Exchange (NYSE). It operates in the Consumer Non-Cyclicals sector.
JBS appears to be a good buy right now due to its current price of $13.03, which is significantly below the analyst price targets of $17.50 and $18. This suggests a potential upside of over 30%. Additionally, the forward P/E ratio of 3.87 indicates that the stock is undervalued compared to its earnings potential. However, the main risk is the recent net loss of $102 million in Q2 2026, which reflects challenges in profitability that investors should monitor closely.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.